Antibody in tears following intranasal vaccination with inactivated virus. II. Enhancement of tear antibody production by the use of polyinosinic: polycytidilic acid (poly I:C).
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects*; D002499:Centrifugation, Density Gradient; D005455:Fluorescent Antibody Technique; D005557:Formaldehyde; D006385:Hemagglutination Inhibition Tests; D007136:Immunoglobulins / Q000032:analysis; D007271:Injections, Intradermal; D008297:Male; D009666:Nose / Q000187:drug effects; D011070:Poly I-C / Q000494:pharmacology; D011119:Polynucleotides / Q000494:pharmacology*; D011817:Rabbits; D013395:Sucrose / Q000032:analysis; D013666:Tears / Q000276:immunology*; D014611:Vaccination; D014616:Vaccinia virus; D014765:Viral Vaccines / Q000008:administration & dosage / Q000494:pharmacology*
D007136:Immunoglobulins; D011119:Polynucleotides; D014765:Viral Vaccines; D005557:Formaldehyde; D013395:Sucrose; D011070:Poly I-C